No matter what type of therapy you are developing, our genomic integrity analysis covers all classes of structural variants delivering the ground truth in data analysis.

We consult with you and write a scope of work customized to your needs, allowing us to identify the crucial questions you want answered about your drug product. The dGH™ platform detects structural variants throughout the genome in an unbiased and targeted manner, even at frequencies below one percent. Rest assured, we’ll uncover any low-frequency occurrences or errors in your drug products. Delivering the ground truth for assessing genomic integrity and stability.